本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fennec Pharmaceuticals Inc.

10.64
-0.0800-0.75%
成交量:25.37萬
成交額:264.51萬
市值:3.73億
市盈率:-88.67
高:10.65
開:10.60
低:10.14
收:10.72
52周最高:13.25
52周最低:5.65
股本:3,506.72萬
流通股本:1,988.67萬
量比:1.05
換手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-0.1200
每股收益(LYR):-0.3409
淨資產收益率:-18.58%
總資產收益率:-1.16%
市淨率:8.79
市盈率(LYR):-31.21

資料載入中...

2026/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities